Company

About

ADALTIS - IVD Manufacturer, Italy

ADALTIS - IVD Manufacturer, Italy

Via Luigi Einaudi 7, Guidonia di Montecelio, Rome, 00012, IT

Adaltis S.r.l. is an international IVD company headquartered in Rome, Italy. Adaltis develops, manufactures and markets in-vitro diagnostic systems and reagents to detect viral infections, diagnose immune system diseases and measure human hormone responses. http://www.adaltis.net/products/ Personal LAB - fully automated 2 plate microELISA/IFA analyser NEXgen - fully automated 7 plate microELISA / IFA analyser EXTRAlab - Robotic systems for liquid handling, extraction/purification of nucleic acids Pchem Family - clinical chemistry systems for 120-500 tests/hour (Instruments and dedicated reagents). HEMO One - Point of Care Analyser (Diabetes / Vitamin deficiencies / Metabolic disorders / Inflammatory diseases) With more than 10 thousands of instruments installed worldwide, Adaltis is known for excellence in performance and innovation. Adaltis' development and production of reagents include a wide range of assays: - Diagnostic kits for detection of infection agents by real-time PCR (MOLgen Line) - MicroELISA kits (EIAgen) - Clinical Chemistry / Turbidity / Latex (CHEMgen) - Genomics & Bioinformatics MDx kits and reagents for DNA/RNA complete extraction kits providing a wide range of clinical specimens (liquids, tissue, cells etc.), compatible with most DNA extraction kits on market. Adaltis provides: Dedicated Customized Services and Antibody Production. Adaltis has a strong record in OEM / ODM development and production of systems and kits. Well known partners have experienced and enjoy the expertise and quality products of Adaltis. Adaltis is ISO 9001 and ISO 13485 certified. Our products are IVD-CE marked. All of our products are backed by dedicated application support and technical service. Customer Care Center: info@adaltis.net Sales and Marketing Office: sales@adaltis.net Order Handling and Logistics: order@adaltis.net Tel: + 39 0774 5791

Avantea

Avantea

Via Porcellasco 7/F, Cremona, CR 26100, IT

Avantea is a laboratory of advanced technologies for biotechnology research and animal reproduction. The activity of this laboratory began in 1991 with Cesare Galli and Giovanna Lazzari. In 2008 it became Avantea Srl, inheriting all the skills and expertise built in about twenty years of activity and the know-how developed through years of research conducted in the biomedical and animal reproduction fields. Credibility and experience make Avantea a reliable and highly specialized center, which aims to find innovative solutions in the field of reproductive biotechnology for livestock breeding and biomedicine. Avantea research activity is assessed by an independent Ethics Committee, which includes leading experts in animal health and welfare, bioethics, genetics, law and forensic medicine and it is in agreement with the guidelines for the application of Article 48 of the Ethics Code of the National Federation of Italian Veterinarians. Avantea has a Quality Management System and obtained the Quality Certification according to UNI EN 9001:2008.

Comecer

Comecer

Via Maestri del Lavoro, 90, Castel Bolognese, Ravenna 48014, IT

Comecer, an ATS company, develops and manufactures high-tech systems for Aseptic Processing and Containment in Pharmaceutical and Nuclear Medicine Industries, specialising in isolation technology solutions for regenerative medicine and tissue engineering. We develop highly innovative technologies and sustainable solutions, according to the latest GMP (Good Manufacturing Practice) regulations. The ability to build tailor-made solutions for our clients has been vital to our success. We operate in industries where each client has unique requirements, so standard solutions in most cases are not a good fit. That's why we always start new projects by listening to client needs and requirements. We assign a dedicated project team that analyses and understands the processes and the environment since no two organizations have identical characteristics. This team collects all the data, studies all aspects and designs solutions. This is where years of experience come into play. We then discuss with the client the possible alternatives that can meet their requirements. Many customers are not aware of how much customization is possible and our proposals surprise them. Containment: isolators to handle highly active principles or excipients (ATEX, where required), isolators to load reactors, multi-stage isolators for chemical synthesis or laboratory operations. Asepsis: isolators for sterility tests and formulation of sterile drugs, isolators/RABs integrated into the liquid or powder filling lines, dedicated solutions for Regenerative Medicine applications. Grade A pharmaceutical continuity: RABs, laminar flow trolleys, transfer hatch (with VPHP, where required). We also operate in the field of nuclear medicine and radiochemistry with the production of shielding systems and equipment for unique applications, for large industrial groups and research organisations, ensuring minimal exposure for the operator, total decontamination and inalterability under any working conditions.

Diatheva

Diatheva

Diatheva S.r.l. Via G. Marconi, 8, 61030 Cartoceto PU, Italy

Founded in 2002 in Cartoceto (PU), Italy, Diatheva is a biotechnology company established as a spin-off from the University of Urbino. 70% of all employees holds at least a PhD and oversees all phases of activity, from research and development to production and finishing. For 20 years, Diatheva has been engaged in the research, development, and production of: - biotechnological products: including monoclonal and polyclonal antibodies, antibody fragments, recombinant proteins, recombinant enzymes, and antigens - molecular and immunoenzymatic assays: such as in vitro diagnostics (IVD), veterinary kits, food analysis kits, and environmental kits. To achieve this, Diatheva collaborates with companies, public and private entities, mainly operating in the fields of oncology, microbial infections, and pharmacogenetics. Diatheva operates a cutting-edge GMP production facility authorized by AIFA since 2006 for biomolecules (APIs) and since 2023 for medicinal products.